EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modeling an ataxic phenotype induced by combined administration of 3-acetylpyridine and lipopolysaccharide

Andrei A. Gerasimov, Dmitry N. Voronkov, Ivan A. Potapov, Anastasia K. Pavlova, Alla V. Stavrovskaya, Sergey N. Illarioshkin

Annals of Clinical and Experimental Neurology · 30.06.2026 · 20 (2) · 46-59

DOI: 10.17816/acen.1507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Experimental Neurology, online erschienen am 30.06.2026. Verfasst von Andrei A. Gerasimov und 5 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Spinocerebellar ataxias lead to severe disability and impose a significant burden on healthcare systems. Experimental models are indispensable for reproducing the behavioral manifestations of ataxia and investigating novel therapeutic approaches; however, they do not fully replicate the entire spectrum of disease symptoms. Combined models are the most promising, as they more accurately reflect the complex pathogenetic mechanisms of neurodegeneration. Study aim: To assess the representativeness of the spinocerebellar ataxia phenotype model following combined exposure to lipopolysaccharide (LPS) and 3-acetylpyridine (3-AP) using behavioral tests. Materials and methods. The study was conducted on male Wistar rats (n = 30), randomly assigned to 4 groups. Animals in the Control+LPS and LPS+3-AP groups received LPS (40 μg in 10 μL) via bilateral intracerebroventricular (ICV) injection; rats in the Control and PS+3-AP groups received an equivalent volume of physiological saline. Three days later, animals in the PS+3-AP and LPS+3-AP groups received intraperitoneal injections of 3-AP (40 mg/kg); the Control and LPS+PS groups received physiological saline. The development of motor impairments was assessed using behavioral tests. Immunohistochemical methods were used to identify Purkinje cell (aldolase C) and microglial (IBA1) markers on cerebellar sections.

Results

Body weight significantly decreased following combined exposure (p 0.01) and 3-AP alone (p 0.05), but not following LPS alone (p 0.05). Motor function impairments were significant in the LPS+3-AP and Control+3-AP groups (p 0.05). In the Control+LPS group, only isolated parameters showed significant changes compared to controls. Qualitative morphological analysis revealed more pronounced Purkinje cell dystrophy and microglial activation following combined exposure.

Conclusion

Combined exposure to LPS and 3-AP reproduces a more pronounced ataxic phenotype, indicating a possible sensitizing effect of neuroinflammation and supporting the utility of this model for further investigation of this process.

Zitieren

APA

Gerasimov, A. A., Voronkov, D. N., Potapov, I. A., Pavlova, A. K., Stavrovskaya, A. V., & Illarioshkin, S. N. (2026). Modeling an ataxic phenotype induced by combined administration of 3-acetylpyridine and lipopolysaccharide. Annals of Clinical and Experimental Neurology, 20(2), 46-59. https://doi.org/10.17816/acen.1507

Vancouver

Gerasimov AA, Voronkov DN, Potapov IA, Pavlova AK, Stavrovskaya AV, Illarioshkin SN. Modeling an ataxic phenotype induced by combined administration of 3-acetylpyridine and lipopolysaccharide. Annals of Clinical and Experimental Neurology. 2026;20(2):46-59. doi:10.17816/acen.1507

BibTeX
@article{Gerasimov2026,
  author = {Gerasimov, Andrei A. and Voronkov, Dmitry N. and Potapov, Ivan A. and Pavlova, Anastasia K. and Stavrovskaya, Alla V. and Illarioshkin, Sergey N.},
  title = {Modeling an ataxic phenotype induced by combined administration of 3-acetylpyridine and lipopolysaccharide},
  journal = {Annals of Clinical and Experimental Neurology},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {46--59},
  doi = {10.17816/acen.1507}
}
Kostenlos starten →